INTRODUCTION
Adult-onset Still' s disease (AOSD) is a systemic inflammatory disease, and its major clinical manifestations include high spiking fever, typical skin rash, polyarthritis, and neutrophilic leukocytosis. The common minor features are sore throat, serositis, lymphadenopathy, splenomegaly, liver dysfunction, and negative results for antinuclear antibodies (ANA) and rheumatoid factor (RF) assay (1) . Although the pathogenesis of AOSD has been investigated from various aspects including infection, immune reaction, genetic factor, environmental factor, and pregnancy or hormonal effects, it has not been clearly identified yet.
Forty to eighty percent of patients with active stage AOSD show increased titers of immunoglobulin (Ig), most of which are IgG, and sometimes, detected as a form of immune complex (IC) (2) (3) (4) . Ig or IC may influence the expression of Fc gamma receptors (Fc Rs) on the surface of phagocytic cells such as monocytes, macrophages, natural killer (NK) cells, and neutrophils. Administration of high-dosage intravenous immunoglobulins (IVIG) may induce remission of active AOSD by means of blocking Fc R or regulating humoral immune response (5) (6) . Patients with AOSD also have high serum levels of interleukin-6 (IL-6), interferon-(INF-), and tumor necrosis factor-(TNF-). IL-6 induced by Fc R triggering may stimulate the ferritin synthesis and B cell proliferation, but the ferritin inhibits Ig production of B cells (7) (8) (9) (10) . Previously, both the concentration of IL-6 and that of serum ferritin have been shown to rise and fall depending on the disease activities in juvenile chronic arthritis and AOSD (11, 12) . Nakatani et al. recently reported that in Kawasaki disease, which has similar clinical features with AOSD in part, high level of Fc R II and III expression on the surfaces of neutrophils and monocytes at active state fell after IVIG therapy (13) .
The polymorphisms of Fc RIIa-131R/H and IIIa-176V/F were also revealed as genetic risk factors for systemic lupus erythematosus (SLE), especially lupus nephritis, and as susceptibility and/or severity markers for SLE and rheumatoid arthritis (RA) in distinct ethnic groups (14) (15) (16) (17) (18) (19) . Fc R polymorphism might be associated with AOSD by means of IC handling, cytokine production, and binding ability to acute phase reactants, such as C-reactive protein (CRP). We investigated whether the polymorphisms of Fc RIIa-131R/H and IIIa-176V/F influence the development and clinical manifestations of AOSD.
Association Between Fc R IIa and IIIa Polymorphism and Clinical Manifestations in Korean Patients with Adult-Onset Still's Disease
High-dose intravenous immunoglobulins alter the disease activity of adult-onset Still' s disease (AOSD). Because activation status of Fc R is possibly dependent on their genetic polymorphisms, we investigated whether the polymorphisms of Fc R IIa and IIIa are risk factors, and affect the clinical features of AOSD. Genomic DNA was extracted from 36 patients and from 197 healthy controls. Polymerase chain reaction for Fc R IIa and IIIa using the allele-specific primers and direct sequencing of Fc R IIIa polymorphic site were performed. The frequencies of Fc R IIa/IIIa genotype between patients with AOSD and controls were not different. The allelic frequencies of Fc R IIa/IIIa between patients with AOSD and controls were not different, either. However, the Fc R IIa-R/R131 genotype was associated with a higher concentration of hemoglobin (p=0.04) and stable liver function (p=0.009) than the other genotypes. The Fc R IIIa-F/F176 genotype was associated with significantly lower titers of serum ferritin (p=0.025), and higher serum albumin (p=0.037) and cholesterol (p=0.014) concentrations than the other genotypes. This study suggest that the Fc R IIa and IIIa polymorphisms might not be genetic risk factors for AOSD in Korean, but contribute to the activity of disease. Fc R IIa-R/R131 and IIIa-F/F176 genotypes, low-binding genotypes for IgG2a and G1, may have more protective effects in acute stage of the disease than the other genotypes.
MATERIALS AND METHODS

Patients
Thirty-six Korean patients with AOSD and 197 Korean healthy controls were enrolled in this study. The patients were recruited between May 1998 and July 1999 at the Hospital for Rheumatic Diseases and Guri Hospital of Hanyang University. Diagnosis of AOSD was made by the criteria of Yamaguchi et al. (1) . We excluded patients with occult infections, malignancy, or definite signs that fulfilled the criteria for other rheumatic diseases. Clinical manifestations and laboratory data at acute stage were collected by interview and retrospective review of medical records.
Disease duration was considered from initial clinical manifestation to September 1999. The clinical parameters included high fever (>39℃), arthritis (involvement of 4 or less joints for oligoarticular type and 5 or more joints for polyarticular type), skin rash, weight loss (>10% for 6 months), lymphadenopathy, hepatomegaly, splenomegaly, and sore throat in physical examination, serositis and renal involvement. The laboratory variables at active stage of the disease included the counts of leukocytes and platelets, hemoglobin level, the serum concentrations of albumin, transaminase (ALT/AST), cholesterol, and ferritin. We determined ANA by an indirect immunofluorescence test using IT-1 cell and RF by nephelometry. We also classified the disease-course into 3 categories; the monocyclic-systemic type was defined as an initial, single bout of systemic disease of variable duration, followed by systemic remission, and the polycyclic-systemic type referred to 2 or more episodes of systemic disease. The chronic destructive type referred to recurrent systemic manifestations, followed by bony erosion and deformities.
Fc R IIa and IIIa genotyping
For genotyping of Fc R IIa and IIIa, DNA was isolated from peripheral blood (Puregene kit, Gentra systems, Minneapolis, MN, U.S.A.). Polymerase chain reaction (PCR) was performed using allele-specific primers (Bioneer Co, Ltd., Cheongwon, Korea). Pan-primer of Fc R IIa was 5′ -TCA AAG TGA AAC AAC AGC CTG ACT AC-3′ . Allele-specific primer of Fc R IIa-131R was 5′ -ATG GAA AAT CCC AGA AAT TCT CAC G-3′ , and that of Fc R IIa-131H was 5′ -ATG GAA AAT CCC AGA AAT TCT CAC A-3′ . Pan-primer of Fc R IIIa was 5′ -TCA CAT ATTTAC AGA ATG GCA ATG G-3′ . Allele-specific primer of Fc R IIIa-F176 was 5′ -TCT CTG AAG ACA CAT TTC TAC TCC CTA A-3′ , and that of Fc R IIIa-V176 was 5′ -TCT CTG AAG ACA CAT TTC TAC TCC CTA C-3′ . The PCR was performed in a Gene Amp system 9600 (Perkin Elmer Biosystem, Norwalk, CT, U.S.A.) with 100 ng of genomic DNA, 10 M of each primer, 100 mM of Tris-HCl, 500 mM of KCl, 15 mM (for IIa) or 25 mM (for IIIa) of MgCl2, 20 mM dNTPs, and 1 unit of Taq DNA polymerase (Boeringer Mannheim Biochemicals, Germany) in a 50 L reaction volume. For Fc R IIa, PCR was started with 94℃ for 5 min, 62℃ for 30 sec, and 72℃ for 3 min, followed by 35 cycles of 94℃ for 45 sec, 62℃ for 30 sec, 72℃ for 45 sec, and ended with an extension step at 72℃ for 10 min. For Fc R IIIa, PCR was started with 94℃ for 5 min, 62℃ for 30 sec, and 72℃ for 3 min, followed by 35 cycles of 94℃ for 30 sec, 55℃ for 30 sec, 72℃ for 30 sec, and ended with an extension step at 72℃ for 7 min. Fifteen microliters of each amplified PCR product was analyzed by gel electrophoresis for 40 min (100 V) on 2% agarose gel containing ethidium bromide. The appearance of 378 (Fc R IIa) or 138 (Fc R IIIa) base pair PCR product in each allele-specific reaction indicate the presence of the allele (15) (16) (17) (18) .
Sequencing of Fc R IIIa genomic DNA
Direct sequencing was performed to confirm the Fc R IIIa genomic sequences for the samples that did not produce definitive patterns on PCR. We amplified a portion of exon 4 that corresponds to the second extracellular Ig-like domain (EC2). The forward primer was 5′ -TGT AAA ACG ACG GCC AGT TCA TCA TAA TTC TGT CTT CT-3′ , corresponding to nt 486-505. The reverse primer was 5′ -CAG GAA ACA GCT ATG ACC CTT GAG TGA TGG TGA TGT TCA-3′ . The size of the PCR product containing the nt 559 polymorphic site was 162 bp.
Fc R IIIa PCR products for sequencing were clarified with 2% agarose gel electrophoresis, and the products were purified with Qiaquick PCR clean-up kit (Qiagen, Germany). Using ABI Prism BigDye TM Terminator Cycle Sequencing Ready Reaction Kits (PE Biosystem, CA, U.S.A.), the purified product was prepared for sequencing. The PCR for BigDye TM adhesion to the purified PCR products was performed by 25 cycles of 96℃ for 30 sec, 50℃ for 15 sec, and 60℃ for 4 min followed by an addition of 2 L of 3 M Na acetate (pH 4.6) and 50 L of 95% ethanol. The samples were mixed carefully and incubated on ice for 10 min. The mixture was then centrifuged for 30 min at 12,000×g, followed by washing with 70% ethanol. The product was resuspended in 25 L of templates suppression reagent (supplied with Ready Reaction Kits), heated at 95℃ for 2 min, then chilled on ice. The samples were read with ABI Prism 310 Genetic Analyzer (PE Biosystem, CA, U.S.A.).
Statistical analysis
The distribution of Fc R IIa and IIIa genotypes between 2 groups (AOSD patients vs. healthy controls) was compared using the Chi-square test (2×2, 2×3 contingency table). A probability of 0.05 (two-tailed) was used to reject the hypothesis that there was no significant difference in the distribution of genotypes between the groups. 2 test was also used to compare the frequency of Fc R IIa-R/R131 (2×2, 2×3 contingency table: R/R131 vs. R/H131 and/or H/H131) and Fc R IIIa-F/F176 (F/F176 vs. V/F176 and/or V/V176), and alleles (R131 vs. H131, F176 vs. V176) in each group. The odds ratios (OR) and 95% confidence interval (95% CI) were calculated to provide an estimate of the risk of AOSD in Fc R IIa and IIIa genotypes or allotype compared with the disease-free controls. The clinical parameters or laboratory variables at active stage of disease were compared using independent sample t-test or ANOVA. We used SPSS version 8.0 for Windows for the statistical analysis.
RESULTS
Clinical features of patients with AOSD
Of the 36 patients with AOSD, 4 were men and 32 were women. The mean age at diagnosis was 31.3±10.4 yr, the mean duration from initial manifestation to diagnosis was 20.0±16.5 months, and the duration of follow-up was 33.6 ±26.1 months. There was no significant difference between the two sexes. During the disease course, 15 patients were classified as oligoarticular type, 16 as polyarticular type, and 3 had no arthritis. Two patients could not be classified because of short disease duration ( (Table 2 ). There was no significant difference between Fc R IIa and IIIa alleles and the clinical parameters (data not shown). The patients with AOSD with the Fc R IIa-R/R131 genotype showed significantly higher concentrations of hemoglobin (p=0.009), and lower concentrations of serum AST (p=0.04) than those with the Fc R IIa-RH/HH genotype ( Table 3 ). The Fc R IIIa-F/F176 genotype was also revealed to be associated with significantly lower titers of serum ferritin (p=0.025), and higher serum albumin (p=0.037) and cholesterol (p=0.014) concentrations than the other genotypes ( Table 4) .
The patients with polyarticular type showed lower concentrations of serum albumin (p=0.025, 3.4±0.5 vs. 3.9±0.6), higher concentrations of serum ferritin (p=0.078, 7,179± 8,907 vs. 2,628±2,858) than those with oligoarticular type. During the disease course, patients with the polycyclic-systemic type revealed higher titers of serum ferritin (p=0.013, 6,657±8,135 vs. 1,735±1,994) than those with the monocyclic-systemic type. The patients with the chronic destructive type marked higher platelet counts (p=0.001, 618,750 ±134,772 vs. 380,326±94,522), and were much more anemic (p=0.04, 8.3±1.2 vs.10.3±1.5) than the other two types. However we could not find any statistically significant correlation between the genotypes and the clinical course due to the small number of patients in each group.
DISCUSSION
Fc Rs play important roles in immune regulation, as they link antibody-mediated immune responses with cellular effector function. Fc Rs have three distinct types: Fc RI, Fc RII, and Fc RIII, with different IgG binding affinities and IgG subclass specificities (20) . The structural heterogeneity of Fc R is reflected in a wide range of biologic activities, including phagocytosis, antibody-dependent cell-mediated cytotoxicity, and release of inflammatory mediator, as well as clearance of antigen/antibody immune complex and regulation of antibody production (21) . Additional diversity of individual Fc receptor-mediated function is related to genetically determined polymorphisms (21) . Fc R IIa alleles (R131 and H131) differ in their capacity to bind IgG2, and Fc R IIIa alleles (V176 and F176) differ in IgG1 and IgG3 binding. In some ethnic populations with lupus, Fc R IIa-R131 and Fc R IIIa-F176, the alleles with a lower binding capacity, were known to be associated with nephritis, whereas Fc R IIa-H131 and Fc R IIIa-V176, the alleles with a high binding capacity, seemed to be protective (14-17, 22, 23) .
Although the pathogenesis of AOSD has not been clearly defined, we speculate that Fc Rs may play a role in the pathogenesis based on the following evidences.
First, the IVIG treatment was effective in steroid-resistant cases of AOSD (5, 24, 25) . The mechanism of action could be IVIG-mediated Fc receptor blockage and modulation. IVIG bound to the Fc R on the surface of B cell induce apoptosis and inhibit the production of Ig or B cell proliferation (26) . In the acute stage of Kawasaki disease, which has similar clinical manifestations with AOSD, the expression of Fc R II and III was modulated by the infusion of IVIG (13, 27) . These findings suggest that the immune system in patients with AOSD could be regulated by modulation of Fc R II and III. Second, 40% to 80% of patients with AOSD have increased IgG level, sometimes in a form of IC (2-4). The abundant IgG in AOSD might bind to auto-antigens or to foreign antigens and then, induce Fc R-mediated immune reactions. Third, AOSD patients in active stage had increased concentrations of IL-6, TNF-, or INF- (11) . Fc R ligation may trigger the release of IL-1, IL-6, and TNF- (8, 28) . Fc R IIIa ligation of human macrophages in RA patients induces production of both TNF-and IL-1 by immune complexes containing IgG RF (29) . Fc R IIIa engagement on the NK cells from V/V high-binding homozygotes led to a larger rise in the concentration of Ca ++ influx ([Ca ++ ]i), a greater level of NK cell activation, and a more rapid induction of activation-induced cell death than F/F low-binding homozygotes (16) . Fc R IIa is a receptor for C-reactive protein on human monocytes and polymorphonuclear leukocytes. Fc R IIa R-131 homozygote binds CRP with a higher affinity and initiates higher increase in [Ca ++ ]i (30) than Fc R IIa H-131 homozygote. Therefore, the production of proinflammatory cytokines and activation of cells in AOSD may be influenced by Fc R polymorphisms. Fourth, the serum ferritin concentration in active AOSD was also significantly higher than that in inactive AOSD (31) . Ferritin has an inhibitory effect on the in vitro proliferation of T lymphocytes and on the differentiation of human B lymphocytes (10). IL-6 increased the transferrin uptake and production of ferritin (32) . TNF, which can be induced by Fc R ligation, may also stimulate the ferritin synthesis (7). Collectively, Fc R polymorphism may influence the serum concentration of ferritin through the cytokine-mediated inflammatory pathway.
Although this study was too underpowered to test the hypothesis due to small sample size, Fc R IIa-R/H131 and IIIa-V/ F176 polymorphisms might not be genetic risk factors for AOSD. However, Fc R IIa-R/R131 genotype was associated with a higher hemoglobin concentration and lower serum transaminase concentration, and Fc R IIIa-F/F176 was associated with a higher concentration of serum albumin and a lower concentration of serum ferritin than the other two genotypes. These data suggest that Fc R IIa-R/R131 and Fc R IIIa-F/F176 genotypes could be protective during the active stage of AOSD, and the difference in cell activation induced by the Fc R polymorphism may influence the concentration of ferritin and albumin, which reflect the level of cytokine release according to the Fc R polymorphisms. The patients with the Fc R IIIa-V/V176 genotype had a higher titer of serum ferritin, which has been known as a marker of disease activity in AOSD, and a lower concentration of serum albumin in the acute stage. These findings are consistent with our previous clinical report (2) , which emphasized that the patients with lower concentrations of serum albumin in the early stage had a recurrent and chronic disease course. However, we could not find any difference in the clinical course by the Fc R polymorphism due to the small number of patients in each group. Fc R polymorphism may affect the level of activation of phagocytic cells in AOSD, whereas it contributes to the lupus pathogenesis as a genetic risk factor by the different capacity to handle IgG-containing immune complex.
In conclusion, there was no significant skewing in the distribution of the Fc R IIa and IIIa genotypes and alleles between the patients with AOSD and disease-free controls. However, Fc R IIa and IIIa polymorphisms might contribute to the process of active disease. Fc R IIa-R/R131 and IIIa-F/F176 genotypes or alleles may provide more protective effects in acute stage of the disease than the other genotypes. Therefore, compared with the defective scavenging of IC in SLE, especially lupus nephritis, Fc R IIa and IIIa polymorphism may affect the effector cell activation via Fc R triggered by IG or IC in AOSD. It will be valuable to assess the relationship between AOSD and Fc R polymorphism with more AOSD patients to confirm our observation.
